Parabolic Drugs has entered the dosage space with an aim to make Rs 150 crore by way of sales within 3-5 years, said director Vineet Gupta.
Vineet Gupta, director of Parabolic Drugs spoke to CNBC-TV18 about the latest with is company and the way ahead.
There are reports stating that Parabolic Drugs is in talks with Japanese firms for bulk supply deals. In an interview to CNBC-TV18, Vineet Gupta, director of Parabolic Drugs confirmed the same.
In an interview with CNBC-TV18’s Latha Venkatesh and Reema Tendulkar, Vineet Gupta, Director of Parabolic Drugs, spoke on their pact with a local company on manufacturing nutraceutical bulk drugs.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.